Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 502 results for "Zohydro"

Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief
SPi World News

Zogenix Reports Zohydro ER Shows Sustained 12-Hour Pain Relief

Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced new post-hoc analysis data showing that the indicated ..., 5 hours ago

13 images for Zohydro

WABC New York City, 49 minutes ago
Champlain Channel, 3 days ago
Champlain Channel, 3 days ago
WABC New York City, 49 minutes ago
SPi World News, 5 hours ago
WABC New York City, 1 month ago, 1 month ago, 2 months ago, 1 month ago, 1 month ago

More on Zogenix Q2 results

Zogenix ( ZGNX ) Q2 results : Total Revenue: $9.2M (+3.4%), Zohydro Sales: $2.4M; Operating Loss: ($45.8M) (-314.0%); Net Income: $62.9M (+572.9%); EPS: $0.45 (+446.2%); Quick Assets: $81.2M (+12.8%). Zohydro ER prescriptions: 10,299. No specific ...
 Seeking Alpha3 weeks ago

Despite The Sell-Off, Zohydro Is A Falling Knife Too Dangerous To Catch

Summary Zohydro will stay on the market after multiple clear signals from the FDA standing by its approval. The real question is if doctors will prescribe the drug given the crowded space with multiple generics options. I spoke with 2 physicians, ...
 Seeking Alpha1 month ago

Judge blocks Massachusetts painkiller restriction

BOSTON -- Massachusetts must temporarily suspend one of its key restrictions on Zohydro, a powerful new prescription painkiller, pending the outcome of a lawsuit challenging their constitutionality, a federal judge ruled on Tuesday. U.S. District ...
 Miami Herald1 month ago
Bidness Etc

Purdue pain pill gets priority review

The FDA grants Priority Review to Purdue for its tamper-resistant pain medication that competes with Zogenix's ( ZGNX ) Zohydro. The agency's review of the company's hydrocodone tablet should take ~six months. Purdue's chronic pain offering is hard ...
 Seeking Alpha1 month ago Why Zogeniz (ZGNX) Stock Is Tumbling Today  TheStreet.com1 month ago Zogenix Falls On Speculation That Its Drug Will Be Taken Off Market  Bidness Etc1 month ago Purdue's Abuse-Resistant Pill Gets FDA Priority Review  Bloomberg1 month ago

New Prescription Opiate Zohydro Has Strong Potential for Abuse Warns Aid in Recovery

, a full service drug and alcohol treatment center, released a statement today regarding the potential for abuse of a dangerous new painkiller, Zohydro, which is marketed to chronic pain sufferers. The drug, an extended-release painkiller that ...
 Digital Journal5 days ago

Zogenix Provides Update on Zohydro(R) ER; Isis Pharma Earns $1M From GSK Hepatitis B Virus Program

Below is a look at some of the headlines for companies that made news in the healthcare sector on July 2, 2014. Zogenix, Inc. (ZGNX) announced an update on its development programs focused on the introduction of abuse deterrent formulations ...
 BioMedReports2 months ago Regeneron, Sanofi Offer Positive Results from Phase 2b of Dupilum; Celgene's Drug OTEZLA Fails Phase III Trial Endpoint  HispanicBusiness.com1 month ago

Sector Update: Healthcare

If approved, the new tablets should be on the market early next year, ZGNX said. Zohydro has been critized by anti-drug abuse advocates because its current formulation does not have deterrents intended to keep individuals from crushing and then ...
 Nasdaq2 months ago Sector Update: Health Care Shares Flat Pre-Market  Nasdaq4 hours ago Sector Update: Health Care Stocks Mixed; Zogenix Finding Investor Support After Turning Q2 Profit  Nasdaq3 weeks ago Sector Update: Health-Care Shares Mixed Pre-Market; TherapeuticsMD Surges 25% on Initiated Analyst Coverage  Nasdaq1 month ago

New England Governors urge HHS to reject Zohydro ER; support Canadian action

News Release — Governor's Office Aug. 29, 2014 MONTPELIER Five New England Governors, including Vermont Gov. Peter Shumlin, this week called on the federal Health and Human Services Department to prevent easily abused and highly addictive ...
 VTDigger.org3 days ago

Zogenix seeks partner, steers Zohydro marketing away from weak New England

Marketing can be a bit like dating. If you're not getting results with one target, then it's best to focus on someone else. That's exactly what Zogenix ($ZGNX) is doing, by tweaking its Zohydro launch strategy. The controversial new ...
 FiercePharma3 weeks ago Zogenix seeks partner steers Zohydro marketing away from weak New England  Big News Network3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less